François-loı̈c Cosset
#150,244
Most Influential Person Now
François-loı̈c Cosset's AcademicInfluence.com Rankings
François-loı̈c Cossetbiology Degrees
Biology
#11187
World Rank
#14566
Historical Rank
Virology
#267
World Rank
#274
Historical Rank
Microbiology
#633
World Rank
#701
Historical Rank
Download Badge
Biology
François-loı̈c Cosset's Degrees
- PhD Virology Université Paris Cité
- Masters Microbiology Université Paris Cité
- Bachelors Biology Université Paris Cité
Similar Degrees You Can Earn
Why Is François-loı̈c Cosset Influential?
(Suggest an Edit or Addition)François-loı̈c Cosset's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes (2003) (1186)
- Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. (2006) (784)
- High-titer packaging cells producing recombinant retroviruses resistant to human serum (1995) (706)
- Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor* (2003) (662)
- EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy (2011) (661)
- An Envelope Glycoprotein of the Human Endogenous Retrovirus HERV-W Is Expressed in the Human Placenta and Fuses Cells Expressing the Type D Mammalian Retrovirus Receptor (2000) (627)
- Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C (2007) (558)
- In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes (2003) (357)
- Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein (2005) (345)
- An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies (2005) (318)
- Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. (2002) (298)
- Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection (2005) (297)
- Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus (2005) (295)
- Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. (2005) (282)
- Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Glycoproteins (2005) (282)
- Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 (2007) (280)
- Characterization of Functional Hepatitis C Virus Envelope Glycoproteins (2004) (254)
- Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell (1994) (250)
- Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase (1996) (248)
- Retroviral retargeting by envelopes expressing an N-terminal binding domain (1995) (241)
- Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure (2015) (241)
- High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI* (2006) (233)
- The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus (2008) (221)
- Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells (2000) (218)
- A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity (2021) (214)
- C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles* (2004) (206)
- Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus (2007) (202)
- Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction (2006) (202)
- Inhibition of hepatitis C virus infection by anti‐claudin‐1 antibodies is mediated by neutralization of E2–CD81–Claudin‐1 associations (2010) (195)
- Cell entry of hepatitis C virus. (2006) (187)
- Cell Cycle Features of Primate Embryonic Stem Cells (2006) (186)
- Continuous high-titer HIV-1 vector production (2003) (184)
- The Envelope Glycoprotein of Human Endogenous Retrovirus Type W Uses a Divergent Family of Amino Acid Transporters/Cell Surface Receptors (2002) (179)
- The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection (2009) (172)
- Virology and cell biology of the hepatitis C virus life cycle: an update. (2014) (172)
- Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. (2010) (165)
- Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. (2004) (163)
- Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes* (2006) (162)
- Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. (2000) (161)
- HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex. (2013) (161)
- A Concerted Action of Hepatitis C Virus P7 and Nonstructural Protein 2 Regulates Core Localization at the Endoplasmic Reticulum and Virus Assembly (2011) (155)
- Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. (2008) (150)
- Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation (2010) (148)
- Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains (2009) (145)
- Development of Minimal Lentivirus Vectors Derived from Simian Immunodeficiency Virus (SIVmac251) and Their Use for Gene Transfer into Human Dendritic Cells (2000) (139)
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins (2019) (139)
- A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques (2011) (135)
- Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. (2014) (133)
- Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination (2021) (132)
- IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. (2003) (130)
- Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps* (2012) (128)
- Targeting retrovirus entry. (1996) (126)
- Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors (1994) (119)
- Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion* (2011) (118)
- A Proline-Rich Motif Downstream of the Receptor Binding Domain Modulates Conformation and Fusogenicity of Murine Retroviral Envelopes (1998) (116)
- Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins (1996) (116)
- The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles (2020) (116)
- Glut1-mediated glucose transport regulates HIV infection (2012) (115)
- Hepatitis C virus replication cycle. (2010) (115)
- High levels of transduction of human dendritic cells with optimized SIV vectors. (2002) (115)
- Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol (2011) (114)
- Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase. (1996) (113)
- Basic Residues in Hypervariable Region 1 of Hepatitis C Virus Envelope Glycoprotein E2 Contribute to Virus Entry (2005) (109)
- High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. (2006) (107)
- Cell Entry of Enveloped Viruses (2011) (107)
- A gene delivery system activatable by disease-associated matrix metalloproteinases. (1997) (107)
- The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus* (2007) (105)
- TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells (2013) (104)
- Targeting retroviral and lentiviral vectors. (2003) (103)
- Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2 (2005) (101)
- Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion. (2008) (100)
- The mechanism of HCV entry into host cells. (2015) (99)
- Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs. (2014) (99)
- Vaccine‐induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD‐1 and chronicity (2007) (97)
- Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. (2002) (96)
- Targeting of retroviral vectors through protease-substrate interactions. (1996) (93)
- Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. (2009) (91)
- Modifying the host range properties of retroviral vectors (1999) (91)
- Activation of a Cell Entry Pathway Common to Type C Mammalian Retroviruses by Soluble Envelope Fragments (2000) (90)
- Strategies for targeting lentiviral vectors. (2008) (88)
- Synthesis, Assembly, and Processing of the Env ERVWE1/Syncytin Human Endogenous Retroviral Envelope (2005) (88)
- Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee (2005) (88)
- Retargeting gene delivery using surface-engineered retroviral vector particles. (2001) (86)
- TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression. (2012) (86)
- Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo (2019) (86)
- Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. (2012) (85)
- Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. (1996) (85)
- Nipah Virus Uses Leukocytes for Efficient Dissemination within a Host (2011) (85)
- Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol. (2007) (85)
- The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination (2013) (85)
- Activation of Membrane Fusion by Murine Leukemia Viruses Is Controlled in cis or in trans by Interactions between the Receptor-Binding Domain and a Conserved Disulfide Loop of the Carboxy Terminus of the Surface Glycoprotein (2001) (84)
- Intracellular Trafficking of Gag and Env Proteins and Their Interactions Modulate Pseudotyping of Retroviruses (2004) (84)
- Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU (1996) (83)
- Retrovirus-mediated gene transfer into human CD34+38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. (1998) (81)
- Intracellular Versus Cell Surface Assembly of Retroviral Pseudotypes Is Determined by the Cellular Localization of the Viral Glycoprotein, Its Capacity to Interact with Gag, and the Expression of the Nef Protein* (2006) (80)
- Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry. (2009) (80)
- Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies. (2012) (78)
- Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors (2001) (78)
- Surface‐engineering of lentiviral vectors (2004) (77)
- Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry (2014) (76)
- Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors (1999) (75)
- Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells (2004) (74)
- HCV transmission by hepatic exosomes establishes a productive infection. (2014) (73)
- IL-7Rα Gene Expression Is Inversely Correlated with Cell Cycle Progression in IL-7-Stimulated T Lymphocytes1 (2006) (73)
- Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. (1998) (73)
- Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity (2005) (73)
- Packaging of Endogenous Retroviral Sequences in Retroviral Vectors Produced by Murine and Human Packaging Cells (1998) (73)
- Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy. (2010) (71)
- Important Role for the Transmembrane Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein during Entry (2006) (70)
- Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. (2002) (70)
- Measles Virus Glycoprotein-Pseudotyped Lentiviral Vector-Mediated Gene Transfer into Quiescent Lymphocytes Requires Binding to both SLAM and CD46 Entry Receptors (2011) (70)
- Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus–Vector Vaccines (2012) (68)
- Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo. (1997) (66)
- In vivo selection of protease cleavage sites from retrovirus display libraries (1998) (65)
- Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses (2006) (65)
- Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. (1999) (65)
- Identification of an Envelope Protein from the FRD Family of Human Endogenous Retroviruses (HERV-FRD) Conferring Infectivity and Functional Conservation among Simians (2004) (64)
- Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells (2016) (64)
- Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. (1996) (64)
- A New System for Stringent, High-Titer Vesicular Stomatitis Virus G Protein-Pseudotyped Retrovirus Vector Induction by Introduction of Cre Recombinase into Stable Prepackaging Cell Lines (1998) (64)
- Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. (2005) (62)
- Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin. (1999) (62)
- DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. (2006) (62)
- Host neutralizing responses and pathogenesis of hepatitis C virus infection (2008) (61)
- A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes (1990) (60)
- Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion (2015) (59)
- Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms. (2016) (58)
- Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope. (1998) (57)
- Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus (2008) (56)
- Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. (2007) (56)
- Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. (2005) (55)
- A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational Epitope (2008) (55)
- Incorporation of Fowl Plague Virus Hemagglutinin into Murine Leukemia Virus Particles and Analysis of the Infectivity of the Pseudotyped Retroviruses (1998) (54)
- Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes (2018) (54)
- Retroviral Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus (1999) (53)
- Polo‐like‐kinase 1 is a proviral host factor for hepatitis B virus replication (2017) (53)
- X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene. (2016) (53)
- Concentration of viral vectors by co‐precipitation with calcium phosphate (2001) (52)
- Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors. (2004) (51)
- Activated Macrophages Promote Hepatitis C Virus Entry in a Tumor Necrosis Factor-Dependent Manner (2014) (50)
- Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector. (2017) (50)
- Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets (2019) (50)
- A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice. (2012) (50)
- Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus Pseudoparticles (2009) (49)
- Studying HCV cell entry with HCV pseudoparticles (HCVpp). (2009) (48)
- Lentiviral transduction of human hematopoietic cells by HIV‐1‐ and SIV‐based vectors containing a bicistronic cassette driven by various internal promoters (2005) (48)
- Strategies for retargeted gene delivery using vectors derived from lentiviruses. (2004) (47)
- Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies (2011) (47)
- Significant Redox Insensitivity of the Functions of the SARS-CoV Spike Glycoprotein (2006) (46)
- Definition of an Amino-terminal Domain of the Human T-cell Leukemia Virus Type 1 Envelope Surface Unit That Extends the Fusogenic Range of an Ecotropic Murine Leukemia Virus* (2000) (46)
- Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells. (2004) (46)
- Germline transmission of exogenous genes in chickens using helper-free ecotropic avian leukosis virus-based vectors (1995) (44)
- Modification of retroviral tropism by display of IGF-I. (1999) (44)
- Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation (2011) (44)
- High level of retrovirus-mediated gene transfer into dendritic cells derived from cord blood and mobilized peripheral blood CD34+ cells. (1999) (43)
- Ciliary Beating Recovery in Deficient Human Airway Epithelial Cells after Lentivirus Ex Vivo Gene Therapy (2009) (42)
- Receptor co‐operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding (1997) (41)
- Relationship between SU Subdomains That Regulate the Receptor-Mediated Transition from the Native (Fusion-Inhibited) to the Fusion-Active Conformation of the Murine Leukemia Virus Glycoprotein (2002) (40)
- Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells. (2015) (39)
- Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice. (2013) (39)
- Lentiviral vectors derived from simian immunodeficiency virus. (2002) (38)
- Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors (1997) (37)
- Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins. (1999) (35)
- Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions. (2006) (35)
- Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development (2009) (35)
- Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells. (2012) (35)
- Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2 (2017) (34)
- Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes (2016) (34)
- Masking of retroviral envelope functions by oligomerizing polypeptide adaptors. (1997) (33)
- Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. (2007) (33)
- Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent. (2017) (33)
- Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein. (2006) (32)
- Identification of Interactions in the E1E2 Heterodimer of Hepatitis C Virus Important for Cell Entry* (2011) (32)
- ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity (2014) (31)
- Lentiviral vector gene transfer into human T cells. (2009) (31)
- Transgenic rabbit production with simian immunodeficiency virus-derived lentiviral vector (2010) (31)
- A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status. (2015) (30)
- Generation of a helper cell line for packaging avian leukosis virus-based vectors (1989) (30)
- Vectors derived from simian immunodeficiency virus (SIV). (2002) (30)
- Monoclonal Antibody AP 33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E 2 Envelope Glycoprotein (2005) (30)
- Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites. (2016) (28)
- Packaging cells for avian leukosis virus-based vectors with various host ranges (1992) (28)
- Endothelial cells are activated by angiopoeitin-1 gene transfer and produce coordinated sprouting in vitro and arteriogenesis in vivo. (2007) (28)
- Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell Leukemia. (2016) (28)
- The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies (2007) (27)
- Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor. (2006) (27)
- Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy (2020) (27)
- Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model* (2015) (27)
- CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes (2013) (26)
- TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions (1996) (25)
- Improvement of avian leukosis virus (ALV)-based retrovirus vectors by using different cis-acting sequences from ALVs (1991) (25)
- Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle. (2002) (25)
- Heparan Sulfate-Dependent Enhancement of Henipavirus Infection (2015) (25)
- Farnesoid X receptor‐α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo (2018) (25)
- Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies (2013) (24)
- An Acidic Cluster of the Cytoplasmic Tail of the RD114 Virus Glycoprotein Controls Assembly of Retroviral Envelopes (2007) (24)
- Scavenger Receptor BI Is a Key Host Factor for Hepatitis C Virus Infection Required for an Entry Step Closely Linked to CD 81 (2009) (24)
- Retroviral gene delivery system activatable by plasmin (1998) (21)
- Contribution of Redox Status to Hepatitis C Virus E2 Envelope Protein Function and Antigenicity* (2008) (21)
- Mutations in the H, F, or M Proteins Can Facilitate Resistance of Measles Virus to Neutralizing Human Anti-MV Sera (2014) (21)
- The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity (2020) (20)
- An Antiproliferative Genetic Screening Identifies a Peptide Aptamer That Targets Calcineurin and Up-regulates Its Activity* (2007) (20)
- A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism (2018) (20)
- A longitudinal study of SARS-CoV-2 infected patients shows high correlation between neutralizing antibodies and COVID-19 severity (2020) (20)
- DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus. (2009) (19)
- Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice. (2016) (19)
- Use of helper cells with two host ranges to generate high-titer retroviral vectors. (1993) (19)
- High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation (2014) (18)
- Sensing of cell-associated HTLV by plasmacytoid dendritic cells is regulated by dense β-galactoside glycosylation (2019) (18)
- Myocardial injury‐induced fibroblast proliferation facilitates retroviral‐mediated gene transfer to the rat heart in vivo (2000) (18)
- Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency. (2019) (18)
- The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental models. (2015) (17)
- T Cell‐specific expression from Mo‐MLV retroviral vectors containing a CD4 mini‐promoter/enhancer (2000) (17)
- Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes (2019) (17)
- Targeted Retroviral Infection of Tumor Cells by Receptor Cooperation (2003) (17)
- Characterization of a semi‐replicative gene delivery system allowing propagation of complementary defective retroviral vectors (2005) (17)
- Mouse ES cells over-expressing the transcription factor NeuroD1 show increased differentiation towards endocrine lineages and insulin-expressing cells. (2009) (17)
- In vivo gene delivery into hCD34+ cells in a humanized mouse model. (2011) (17)
- Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing (2019) (16)
- Lentiviral vectors and transduction of human cancer B cells. (2010) (16)
- A universal transgene silencing method based on RNA interference. (2004) (16)
- Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-beuraminidase glycoprotein (1991) (16)
- Gene transfer and genetic modification of embryonic stem cells by Cre‐ and Cre‐PR‐expressing MESV‐based retroviral vectors (2004) (16)
- Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-neuraminidase glycoprotein. (1991) (15)
- Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus (2021) (15)
- A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu. (2019) (15)
- A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation. (2019) (14)
- The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types (2017) (14)
- A Point Mutation in the N-Terminal Amphipathic Helix α0 in NS3 Promotes Hepatitis C Virus Assembly by Altering Core Localization to the Endoplasmic Reticulum and Facilitating Virus Budding (2017) (14)
- Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency. (2017) (14)
- Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis patients (2021) (13)
- Erratum: Receptor co-operation in retrovirus entry: Recruitment of an auxiliary entry mechanism after retargeted binding (The EMBO Journal (1997) 16 (1214-1223)) (1997) (13)
- Homologous and nonhomologous retroviral recombinations are both involved in the transfer by infectious particles of defective avian leukosis virus-derived transcomplementing genomes (1996) (13)
- Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells (2021) (13)
- Retroviral vectors for the expression of two genes in human multipotent neural precursors and their differentiated neuronal and glial progeny. (1999) (13)
- Importance of 3' non-coding sequences for efficient retrovirus-mediated gene transfer in avian cells revealed by self-inactivating vectors. (1993) (13)
- Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line. (1995) (12)
- Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C (2015) (12)
- Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients (2015) (11)
- HDV-Like Viruses (2021) (11)
- Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp). (2009) (10)
- Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential Pathogenicities and Species Specificities of Hepadnaviruses in Primates, Rodents, and Bats (2018) (10)
- Leukemogenicity of v-myb-transformed monoblasts cells can be modulated by normal bone marrow environment. (1993) (10)
- Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production (2021) (9)
- A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis In Vitro. (2019) (9)
- HCV Interplay with Lipoproteins: Inside or Outside the Cells? (2020) (9)
- Addressing the next challenges: A summary of the 22nd international symposium on hepatitis C virus and related viruses. (2016) (9)
- Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques. (2012) (9)
- In situ expression of helper-free avian leukosis virus (ALV)-based retrovirus vectors in early chick embryos. (1992) (9)
- Patterns of integration and expression of retroviral, non-replicative vectors in avian embryos: embryo developmental stage and virus subgroup envelope modulate tissue-tropism. (1993) (8)
- Report of One-Year Prospective Surveillance of SARS-CoV-2 in Dogs and Cats in France with Various Exposure Risks: Confirmation of a Low Prevalence of Shedding, Detection and Complete Sequencing of an Alpha Variant in a Cat (2021) (8)
- Molecular determinants of SR-B1-dependent Plasmodium sporozoite entry into hepatocytes (2020) (8)
- Analysis of ALV-based packaging cell lines for production of contaminant defective viruses. (1995) (8)
- Towards Physiologically and Tightly Regulated Vectored Antibody Therapies (2020) (8)
- The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles. (2020) (8)
- Preliminary evidence for hdv exposure in apparently non-HBV-infected patients. (2020) (7)
- Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles (2007) (7)
- Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies (2021) (7)
- The Mouse IAPE Endogenous Retrovirus Can Infect Cells through Any of the Five GPI-Anchored EphrinA Proteins (2011) (7)
- Transposable elements behavior following viral genomic stress inDrosophila melanogaster inbred line (1996) (7)
- Reconstitution of the myeloid and lymphoid compartments after the transplantation of autologous and genetically modified CD34+ bone marrow cells, following gamma irradiation in cynomolgus macaques (2008) (7)
- Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors (2021) (7)
- HCV and lipoproteins: Is oxLDL an Achilles' heel of the Trojan horse? (2006) (7)
- T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates (2016) (7)
- Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction (2020) (7)
- Engineering the surface glycoproteins of lentiviral vectors for targeted gene transfer. (2009) (7)
- MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. (2001) (6)
- Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Post-Binding Steps and Membrane Fusion (2008) (6)
- Immune response and resistance to Rous sarcoma virus challenge of chickens immunized with cell-associated glycoproteins provided with a recombinant avian leukosis virus (1991) (6)
- Production of lentiviruses displaying ''early-acting'' cytokines for selective gene transfer into hematopoietic stem cells. (2008) (6)
- Antigen-specific tolerance approach for rheumatoid arthritis: past, present and future. (2021) (6)
- Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates (2001) (6)
- A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process (2021) (5)
- Hematopoietic stem cell targeting with surface-engineered lentiviral vectors. (2009) (5)
- Generation of transgenic mice expressing EGFP protein fused to NP68 MHC class I epitope using lentivirus vectors (2013) (5)
- Structure and expression of endogenous retroviral sequences in the permanent LMH chicken cell line. (1995) (5)
- Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures (2021) (5)
- A novel lentivector targets gene transfer into hHSC in marrow from patients with BM-failure-syndrome and in vivo in humanized mice (2011) (4)
- The mouse IAPE endogenous retrovirus can infect cells through any of the five GPI-anchored EphrinA proteins (2011) (4)
- Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins. (2000) (4)
- Acute hepatitis C virus infection induces anti‐host cell receptor antibodies with virus‐neutralizing properties (2015) (4)
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins (2017) (3)
- Vectors derived from avian leukosis and sarcoma viruses (1995) (3)
- Too smart to fail-how viruses exploit the complexity of host cells during entry. (2011) (3)
- Hepatitis C virus core protein uses triacylglycerols to fold onto the endoplasmic reticulum membrane (2022) (3)
- O.171 HDL inhibits HCV neutralisation by CD81-NOB antibodies by stimulating cell entry through activation of the scavenger receptor BI (2006) (2)
- A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry site. (2009) (2)
- Contribution of the charged residues of HCV glycoprotein E2 transmembrane domain to the functions of E1E2 heterodimer. (2005) (2)
- 1. Measles Virus Glycoprotein Pseudotyped Lentiviral Vectors Transduce Cytokine Stimulated and Resting Hematopoietic Stem Cells at an Efficiency Without Precedent (2015) (2)
- HIV fusion: Catch me if you can (2020) (2)
- SIV Vectors. (2003) (2)
- Unlike for cellular mRNAs and other viral internal ribosome entry sites (IRESs), the eIF3 subunit e is not required for the translational activity of the HCV IRES (2020) (2)
- The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing optimal formation of VLPs in presence of Nucleoprotein (2020) (2)
- Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction (2015) (2)
- A master regulator of tight junctions involved in hepatitis C virus entry and pathogenesis (2017) (2)
- Crimean-Congo hemorrhagic fever: a growing threat to Europe. (2022) (1)
- Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies (2021) (1)
- Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patients (2015) (1)
- Inadvertent autoimmunity in EPO gene transfer (2004) (1)
- 607 NEUTRALIZING HOST RESPONSES IN HEPATITIS C VIRUS INFECTION TARGET VIRAL ENTRY AT POST-BINDING STEPS AND MEMBRANE FUSION (2008) (1)
- Functional Mapping of Hepatitis C Virus Envelope-Heparan Sulfate Interaction (2005) (1)
- Membrane Fusion Assays for Studying Entry Hepatitis C Virus into Cells. (2018) (1)
- Production of SIV vectors for gene delivery. (2011) (1)
- ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity (2014) (1)
- Nup98 Is Subverted from Annulate Lamellae by Hepatitis C Virus Core Protein to Foster Viral Assembly (2022) (1)
- 145 VIRAL ENTRY AND ESCAPE FROM ANTIBODY-MEDIATED NEUTRALIZATION ARE KEY DETERMINANTS FOR THE SELECTION OF HEPATITIS C VIRUS VARIANTS DURING LIVER TRANSPLANTATION (2008) (1)
- Growth Genes for the Local and Immune-mediated Control of Tumor Fusogenic Membrane Glycoproteins As a Novel Class of Updated (2000) (1)
- Vector particles to target CD34 (2008) (0)
- Receptor co‐operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding (0)
- HDL-mediated neutralisation-attenuation of HCV-1-Revised Manuscript JBC M6:02706 HIGH DENSITY LIPOPROTEIN INHIBITS HEPATITIS C VIRUS NEUTRALISING ANTIBODIES BY STIMULATING CELL ENTRY VIA ACTIVATION OF THE SCAVENGER RECEPTOR BI (2006) (0)
- Flow cytometry analysis of hematopoiesis reconstitution (2011) (0)
- S1462399411001785jrv 1..20 (2011) (0)
- Floriane transfer into early-cytokine-stimulated and resting HSCs Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene (2014) (0)
- Cell-based vector delivery for cancer gene therapy [Abstract] (2001) (0)
- Fusogenic membrane glycoproteins - A novel class of cytotoxic genes with immunostimulatory properties. (1999) (0)
- O54 SPONTANEOUS RESOLUTION OF HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH THE PRESENCE OF ANTI-RECEPTOR ANTIBODIES IN A COHORT OF SINGLE-SOURCE OUTBREAK (2014) (0)
- 1999 Referees (1999) (0)
- A method of detecting expression of an envelope protein of a retrovirus endogenous human and uses of a gene encoding this protein (1999) (0)
- Allosteric Modulators CTD C-terminal domain A alanine D aspartic acid WCE Whole Cell Extract MAPK Mitogen Activated Protein Kinase HTA Host Targeting Agent DAA Direct Acting Agent RNAi Ribonucleic Acid interference PIV 5 (2017) (0)
- Do NSm virulence factors in the Bunyavirales order originate from Gn gene duplication? (2023) (0)
- Generation ofaHelper CellLineforPackaging AvianLeukosis Virus-Based Vectors (1989) (0)
- FXR agonist GW4064 represses HBV replication in adult but not in young C3H/HeN mice after HBV transduction with rAAV2/8-HBV (2018) (0)
- Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms. (2023) (0)
- [Extracellular maturation of hepatitis C virus: a plasma cloak of invisibility]. (2019) (0)
- Author response: A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process (2021) (0)
- Integrating vectors and expression of a heterologous gene, cells infected with these vectors and method for producing a protein or genetic modification of animals (1987) (0)
- P.169 Targeting of hepatitis C virus-heparan sulfate by human anti-viral antibodies (2006) (0)
- Structural Basis of Neutralization by Human Antibodies Targeting Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Gc (2020) (0)
- A large-scale serological survey in pets from October 2020 through June 2021 in France shows significantly higher exposure to SARS-CoV-2 in cats (2023) (0)
- Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo (2019) (0)
- A. Bateman, et al, Cancer Res., 60: 2492–2497, 2000. (2000) (0)
- envelope protein, methods and uses (1998) (0)
- 826. Transduction of Human Hematopoietic Stem Cells by RD114-TR-Pseudotyped Lentiviral Vectors (2006) (0)
- HCV Core protein needs triacylglycerols to fold onto the endoplasmic reticulum membrane. (2021) (0)
- [Hepatitis C virus cell entry]. (2006) (0)
- 54 Cellular binding and entry of hepatitis C virus pseudotypes and virus-like particles requires a different set of cellular co-receptors (2006) (0)
- 79 Induction of virus-neutralizing antibodies is associated with viral clearance in a single-source outbreak of hepatitis C (2006) (0)
- [68] INSIGHTS IN HCV PERSISTENCE: IDENTIFICATION OF VIRAL AND CELLULAR FACTORS THAT DESENSITISE THE NEUTRALISING ANTIBODY RESPONSE AGAINST HCV AND FAVOUR ITS IMMUNE ESCAPE (2007) (0)
- Involvement of the phosphatidylinositol 4-kinases of type III at the entry and replication stages of the Hepatitis C Virus life cycle (2009) (0)
- Characterization of Lassa virus cell entry and neutralization with Lassa pseudoparticles (2009) (0)
- 16 TRANSITORY REPLICATION OF HCV (JFH1 STRAIN) IN HEPG2 AND HEPA-RG CELLS: CONTRIBUTION OF THE MODE OF GENOME DELIVERY AND MODULATION OF INNATE IMUNE RESPONSES (2008) (0)
- 290. Baboon Envelope Pseudo Typed Lentiviral Vectors Mediate High-Level Gene Transfer in Human B Cells Allowing Secretion of FIX at Therapeutic Levels in NSG Mouse (2015) (0)
- 398. Transduction of Human Hematopoietic Stem Cells and T-Lymphocytes with RD114-TR-Pseudotyped Lentiviral Vectors (2004) (0)
- Molecular and serological evidence of Crimean-Congo hemorrhagic fever orthonairovirus prevalence in livestock and ticks in Cameroon (2023) (0)
- recombinant viral particle comprising a peptide having properties masking and Unmasking vis-a-vis a biological mechanism (1996) (0)
- 398 HUMORAL NEUTRALIZING RESPONSE TO HCV DURING HIV COINFECTION AND LIVER TRANSPLANTATION (2009) (0)
- Cellular Binding and Entry of Hepatitis C Virus Pseudotypes and Virus-like Particles Requires a Different Set of Cellular Co-receptors (2006) (0)
- Gene transfer into birds using ALV-based retrovirus vectors (1991) (0)
- IL-7 Differentially Regulates Cell Cycle Entry and Exit of Naive and Memory CD4+ T Lymphocytes: Effects on HIV-Mediated Infection. (2005) (0)
- 784 CELL ENTRY FACTOR USAGE AND VIRAL EVASION IN HEPATITIS C VIRUS INFECTION IN VIVO (2011) (0)
- A protein coevolution method designed for conserved sequences uncovers critical features of the original HCV fusion mechanism and provides molecular basis for the design of effective antiviral strategies (2018) (0)
- Molecular determinants of SR-B1-dependent Plasmodium sporozoite entry into hepatocytic cells (2020) (0)
- Erratum: (Cancer Research (2000) 60 (1492-1497)) (2000) (0)
- Gene Transfer into Cultured Cardiac Myocytes Mediated by Retrovirus (1999) (0)
- O.192 Scavenger receptor class B type I is a co-receptor for infection with cell culture-derived hepatitis C virus (2006) (0)
- Arabinogalactanes, apiogalacturonanes and heteroglycans sulphate for the treatment of diseases caused by influenza virus (2011) (0)
- Method for detecting the expression of a coat protein of a human endogenous retrovirus and uses a gene encoding this protein (2000) (0)
- P.197 Baseline neutralizing responses predict the virological response to pegylated interferon alpha-ribavirin combination therapy (2006) (0)
- Using T cells to deliver transgenes to target cells: antigen specific virus production and tissue-specific transgene expression for targeted delivery [Abstract] (2002) (0)
- Persistence of Hepatitis C Virus Infection Despite the Presence of Cross-neutralizing Antibodies in a Single-Source Outbreak of Hepatitis C (2006) (0)
- Abstract 1296: Induction of Arteriogenesis by Use of Autologous Venous Endothelial and Smooth Muscle Cells Modified to Express Ang-1 and VEGF (2007) (0)
- 1 Host Neutralizing Responses and Pathogenesis of Hepatitis C Virus Infection (2009) (0)
- Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes (2018) (0)
- Maturation extracellulaire du virus de l’hépatite C (2019) (0)
- O.137 HDL inhibits neutralisation by HCV antibodies via a ternary interaction with the scavenger receptor BI (2006) (0)
- M1804 Humoral Neutralizing Response to HCV During HIV Coinfection and Liver Transplantation (2009) (0)
- Chimeric plasmid containing replicative retroviral genome, useful for making positive control virions in testing for replication-competent retrovirus (2001) (0)
- Prevents Hepatitis C Virus by Blocking Transfer of Viral Genome to Assembly Sites Bertrand Boson (2016) (0)
- [The hepatitis delta virus: an easily turncoat pathogen?] (2020) (0)
- Retroviral vectors are produced by resistant to lysis by human serum production cell (1995) (0)
- Antiviral properties and liver specific delivery of a TLR1/2 ligand in HBV-infected in vitro and in vivo models (2018) (0)
- Human endothelial precursor cells as carriers for therapeutic gene delivery to tumors [Abstract] (2003) (0)
- 646 NEUTRALIZATION OF HEPATITIS C IN CHRONICALLY INFECTED SUBJECTS: INFLUENCE OF HIV COINFECTION, LIVER TRANSPLANTATION AND SEVERITY OF LIVER DISEASE (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With François-loı̈c Cosset?
François-loı̈c Cosset is affiliated with the following schools:
